vs

Side-by-side financial comparison of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and SunPower Inc. (SPWR). Click either name above to swap in a different company.

SunPower Inc. is the larger business by last-quarter revenue ($79.7M vs $44.6M, roughly 1.8× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). SunPower Inc. runs the higher net margin — -17.8% vs -90.4%, a 72.7% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -10.1%). Over the past eight quarters, SunPower Inc.'s revenue compounded faster (118.7% CAGR vs 7.3%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

SunPower Corporation is an American provider of photovoltaic solar energy generation systems and battery energy storage products, primarily for residential customers. The company, headquartered in San Jose, California, was founded in 1985 by Richard Swanson, an electrical engineering professor from Stanford University. Cypress Semiconductor bought a majority interest in the company in 2002, growing it quickly until SunPower went public in 2005. TotalEnergies, a French energy and oil company p...

PACB vs SPWR — Head-to-Head

Bigger by revenue
SPWR
SPWR
1.8× larger
SPWR
$79.7M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+23.9% gap
PACB
13.8%
-10.1%
SPWR
Higher net margin
SPWR
SPWR
72.7% more per $
SPWR
-17.8%
-90.4%
PACB
Faster 2-yr revenue CAGR
SPWR
SPWR
Annualised
SPWR
118.7%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PACB
PACB
SPWR
SPWR
Revenue
$44.6M
$79.7M
Net Profit
$-40.4M
$-14.2M
Gross Margin
37.1%
35.5%
Operating Margin
-92.3%
-27.4%
Net Margin
-90.4%
-17.8%
Revenue YoY
13.8%
-10.1%
Net Profit YoY
-1802.7%
-130.1%
EPS (diluted)
$-0.11
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACB
PACB
SPWR
SPWR
Q4 25
$44.6M
$79.7M
Q3 25
$38.4M
$22.0M
Q2 25
$39.8M
$67.5M
Q1 25
$37.2M
$82.7M
Q4 24
$39.2M
$88.7M
Q3 24
$40.0M
Q2 24
$36.0M
Q1 24
$38.8M
Net Profit
PACB
PACB
SPWR
SPWR
Q4 25
$-40.4M
$-14.2M
Q3 25
$-38.0M
$-16.9M
Q2 25
$-41.9M
$-22.4M
Q1 25
$-426.1M
$8.1M
Q4 24
$2.4M
$47.0M
Q3 24
$-60.7M
Q2 24
$-173.3M
Q1 24
$-78.2M
Gross Margin
PACB
PACB
SPWR
SPWR
Q4 25
37.1%
35.5%
Q3 25
41.4%
Q2 25
36.9%
42.6%
Q1 25
-3.7%
48.5%
Q4 24
25.6%
46.5%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
PACB
PACB
SPWR
SPWR
Q4 25
-92.3%
-27.4%
Q3 25
-101.1%
-15.7%
Q2 25
-112.8%
-4.0%
Q1 25
-1154.5%
1.3%
Q4 24
-390.1%
-24.2%
Q3 24
-160.3%
Q2 24
-488.3%
Q1 24
-209.6%
Net Margin
PACB
PACB
SPWR
SPWR
Q4 25
-90.4%
-17.8%
Q3 25
-98.9%
-76.9%
Q2 25
-105.4%
-33.2%
Q1 25
-1146.8%
9.8%
Q4 24
6.0%
53.0%
Q3 24
-151.9%
Q2 24
-481.3%
Q1 24
-201.4%
EPS (diluted)
PACB
PACB
SPWR
SPWR
Q4 25
$-0.11
$-0.05
Q3 25
$-0.13
$-0.19
Q2 25
$-0.14
$-0.28
Q1 25
$-1.44
$0.00
Q4 24
$-0.44
$0.27
Q3 24
$-0.22
Q2 24
$-0.64
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACB
PACB
SPWR
SPWR
Cash + ST InvestmentsLiquidity on hand
$279.5M
$9.6M
Total DebtLower is stronger
$164.8M
Stockholders' EquityBook value
$5.3M
$-90.1M
Total Assets
$784.1M
$241.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACB
PACB
SPWR
SPWR
Q4 25
$279.5M
$9.6M
Q3 25
$298.7M
$5.1M
Q2 25
$314.7M
$11.1M
Q1 25
$343.1M
$10.6M
Q4 24
$389.9M
$13.4M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Total Debt
PACB
PACB
SPWR
SPWR
Q4 25
$164.8M
Q3 25
$204.3M
Q2 25
$152.9M
Q1 25
Q4 24
$147.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PACB
PACB
SPWR
SPWR
Q4 25
$5.3M
$-90.1M
Q3 25
$36.1M
$-112.3M
Q2 25
$61.5M
$-107.2M
Q1 25
$91.6M
$-89.0M
Q4 24
$506.6M
$-97.5M
Q3 24
$453.1M
Q2 24
$492.7M
Q1 24
$649.0M
Total Assets
PACB
PACB
SPWR
SPWR
Q4 25
$784.1M
$241.2M
Q3 25
$803.2M
$208.3M
Q2 25
$825.5M
$163.1M
Q1 25
$860.8M
$147.8M
Q4 24
$1.3B
$144.5M
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACB
PACB
SPWR
SPWR
Operating Cash FlowLast quarter
$-19.1M
$-1.9M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACB
PACB
SPWR
SPWR
Q4 25
$-19.1M
$-1.9M
Q3 25
$-18.7M
$-6.4M
Q2 25
$-29.4M
$-4.4M
Q1 25
$-44.1M
$-2.6M
Q4 24
$-30.6M
$-25.6M
Q3 24
$-45.5M
Q2 24
$-54.3M
Q1 24
$-75.7M
Free Cash Flow
PACB
PACB
SPWR
SPWR
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
PACB
PACB
SPWR
SPWR
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
PACB
PACB
SPWR
SPWR
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
PACB
PACB
SPWR
SPWR
Q4 25
Q3 25
Q2 25
Q1 25
-0.32×
Q4 24
-12.93×
-0.54×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

SPWR
SPWR

Residential Solar Installation$46.9M59%
New Homes Business$22.7M29%
Other$10.1M13%

Related Comparisons